Arcus Biosciences Inc
NYSE:RCUS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Arcus Biosciences Inc
NYSE:RCUS
|
US |
|
Transrail Lighting Ltd
NSE:TRANSRAILL
|
IN |
|
Swastika Investmart Ltd
BSE:530585
|
IN |
|
Abb Ltd
OTC:ABLZF
|
CH |
|
American Outdoor Brands Inc
NASDAQ:AOUT
|
US |
|
J
|
J-Long Group Ltd
NASDAQ:JL
|
HK |
|
C
|
Copperwired PCL
SET:CPW
|
TH |
|
Huajin International Holdings Ltd
HKEX:2738
|
CN |
|
Rosseti Tsentr PAO
MOEX:MRKC
|
RU |
|
E
|
Ewein Bhd
KLSE:EWEIN
|
MY |
|
PagerDuty Inc
NYSE:PD
|
US |
|
Geopacific Resources Ltd
ASX:GPR
|
AU |
|
SpiderPlus & Co
TSE:4192
|
JP |
Wall Street
Price Targets
RCUS Price Targets Summary
Arcus Biosciences Inc
According to Wall Street analysts, the average 1-year price target for
RCUS
is 34.48 USD
with a low forecast of 20.2 USD and a high forecast of 51.45 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is RCUS's stock price target?
Price Target
34.48
USD
According to Wall Street analysts, the average 1-year price target for
RCUS
is 34.48 USD
with a low forecast of 20.2 USD and a high forecast of 51.45 USD.
What is Arcus Biosciences Inc's Revenue forecast?
Projected CAGR
-1%
For the last 8 years the
compound annual growth rate for
Arcus Biosciences Inc's revenue is
91%.
The projected
CAGR
for the next 3 years is
-1%.
